Protagonist Therapeutics Inc buy Truist Financial Co.
Start price
11.03.25
/
50%
€50.50
Target price
11.03.26
€70.01
Performance (%)
66.34%
End price
12.03.26
€84.00
Summary
This prediction ended on 12.03.26 with a price of €84.00. With a performance of 66.34% the BUY prediction by Truist_Financial_Co_ was a big success. Truist_Financial_Co_ has a follow-up prediction for Protagonist Therapeutics Inc where he still thinks Protagonist Therapeutics Inc is a Buy. Truist_Financial_Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Protagonist Therapeutics Inc | 0.000% | 0.000% | 177.083% |
| iShares Core DAX® | -1.059% | 5.007% | 6.596% |
| iShares Nasdaq 100 | -2.387% | 0.864% | 25.791% |
| iShares Nikkei 225® | -4.361% | 1.211% | 41.309% |
| iShares S&P 500 | -1.778% | 1.391% | 21.037% |
Comments by Truist_Financial_Co_ for this prediction
In the thread Protagonist Therapeutics Inc diskutieren
Protagonist Therapeutics, Inc. (NASDAQ: PTGX) had its price target raised by analysts at Truist Financial Co. from $60.00 to $76.00. They now have a "buy" rating on the stock.
Ratings data for PTGX provided by MarketBeat
In the thread Trading Protagonist Therapeutics Inc
Die von Truist_Financial_Co_ gewählte maximale Laufzeit wurde überschritten
Current prediction by Truist_Financial_Co_ for Protagonist Therapeutics Inc
Protagonist Therapeutics Inc
Start price
Target price
Perf. (%)
€66.00
28.10.25
28.10.25
€75.49
28.10.26
28.10.26
101.52%
19.08.26
19.08.26
Stopped prediction by Truist_Financial_Co_ for Protagonist Therapeutics Inc
Protagonist Therapeutics Inc
Start price
Target price
Perf. (%)
€130.00
10.08.26
10.08.26
€147.14
10.08.27
10.08.27
2.31%
19.08.26
19.08.26
Protagonist Therapeutics Inc
Start price
Target price
Perf. (%)
€50.50
09.09.24
09.09.24
€54.34
09.09.25
09.09.25
4.95%
10.09.25
10.09.25